Covid-19 Impact on Global Respiratory Disorders Drugs Market Size, Status and Forecast 2020-2026

July 2020 | 95 pages | ID: C256AA9D3D37EN
QYResearch

Abstracts

This report focuses on the global Respiratory Disorders Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory Disorders Drugs development in North America, Europe, China and Japan.

The key players covered in this study

• Novartis
• Sanofi
• Teva Pharmaceutical
• Merck & Co.
• Sumitomo Dainippon Pharma
• Mylan
• AstraZeneca
• Boehringer Ingelheim International
• Vertex Pharmaceuticals Incorporated
• Roche
• GlaxoSmithKline

Market segment by Type, the product can be split into

• Oral
• Nasal
• Injectable

Market segment by Application, split into

• Hospital
• Retail Pharmacy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Respiratory Disorders Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Respiratory Disorders Drugs development in North America, Europe, China and Japan.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Respiratory Disorders Drugs are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Respiratory Disorders Drugs Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Respiratory Disorders Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Nasal
  1.4.4 Injectable
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Respiratory Disorders Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Retail Pharmacy
1.6 Coronavirus Disease 2019 (Covid-19): Respiratory Disorders Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Respiratory Disorders Drugs Industry
    1.6.1.1 Respiratory Disorders Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Respiratory Disorders Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Respiratory Disorders Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Respiratory Disorders Drugs Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Respiratory Disorders Drugs Growth Trends by Regions
  2.2.1 Respiratory Disorders Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Respiratory Disorders Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Respiratory Disorders Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Respiratory Disorders Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Respiratory Disorders Drugs Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Respiratory Disorders Drugs Players by Market Size
  3.1.1 Global Top Respiratory Disorders Drugs Players by Revenue (2015-2020)
  3.1.2 Global Respiratory Disorders Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Respiratory Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Respiratory Disorders Drugs Market Concentration Ratio
  3.2.1 Global Respiratory Disorders Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Respiratory Disorders Drugs Revenue in 2019
3.3 Respiratory Disorders Drugs Key Players Head office and Area Served
3.4 Key Players Respiratory Disorders Drugs Product Solution and Service
3.5 Date of Enter into Respiratory Disorders Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Respiratory Disorders Drugs Historic Market Size by Type (2015-2020)
4.2 Global Respiratory Disorders Drugs Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Respiratory Disorders Drugs Market Size by Application (2015-2020)
5.2 Global Respiratory Disorders Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Respiratory Disorders Drugs Market Size (2015-2020)
6.2 Respiratory Disorders Drugs Key Players in North America (2019-2020)
6.3 North America Respiratory Disorders Drugs Market Size by Type (2015-2020)
6.4 North America Respiratory Disorders Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Respiratory Disorders Drugs Market Size (2015-2020)
7.2 Respiratory Disorders Drugs Key Players in Europe (2019-2020)
7.3 Europe Respiratory Disorders Drugs Market Size by Type (2015-2020)
7.4 Europe Respiratory Disorders Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Respiratory Disorders Drugs Market Size (2015-2020)
8.2 Respiratory Disorders Drugs Key Players in China (2019-2020)
8.3 China Respiratory Disorders Drugs Market Size by Type (2015-2020)
8.4 China Respiratory Disorders Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Respiratory Disorders Drugs Market Size (2015-2020)
9.2 Respiratory Disorders Drugs Key Players in Japan (2019-2020)
9.3 Japan Respiratory Disorders Drugs Market Size by Type (2015-2020)
9.4 Japan Respiratory Disorders Drugs Market Size by Application (2015-2020)

10KEY PLAYERS PROFILES

10.1 Novartis
  10.1.1 Novartis Company Details
  10.1.2 Novartis Business Overview and Its Total Revenue
  10.1.3 Novartis Respiratory Disorders Drugs Introduction
  10.1.4 Novartis Revenue in Respiratory Disorders Drugs Business (2015-2020))
  10.1.5 Novartis Recent Development
10.2 Sanofi
  10.2.1 Sanofi Company Details
  10.2.2 Sanofi Business Overview and Its Total Revenue
  10.2.3 Sanofi Respiratory Disorders Drugs Introduction
  10.2.4 Sanofi Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.2.5 Sanofi Recent Development
10.3 Teva Pharmaceutical
  10.3.1 Teva Pharmaceutical Company Details
  10.3.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  10.3.3 Teva Pharmaceutical Respiratory Disorders Drugs Introduction
  10.3.4 Teva Pharmaceutical Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.3.5 Teva Pharmaceutical Recent Development
10.4 Merck & Co.
  10.4.1 Merck & Co. Company Details
  10.4.2 Merck & Co. Business Overview and Its Total Revenue
  10.4.3 Merck & Co. Respiratory Disorders Drugs Introduction
  10.4.4 Merck & Co. Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.4.5 Merck & Co. Recent Development
10.5 Sumitomo Dainippon Pharma
  10.5.1 Sumitomo Dainippon Pharma Company Details
  10.5.2 Sumitomo Dainippon Pharma Business Overview and Its Total Revenue
  10.5.3 Sumitomo Dainippon Pharma Respiratory Disorders Drugs Introduction
  10.5.4 Sumitomo Dainippon Pharma Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.5.5 Sumitomo Dainippon Pharma Recent Development
10.6 Mylan
  10.6.1 Mylan Company Details
  10.6.2 Mylan Business Overview and Its Total Revenue
  10.6.3 Mylan Respiratory Disorders Drugs Introduction
  10.6.4 Mylan Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.6.5 Mylan Recent Development
10.7 AstraZeneca
  10.7.1 AstraZeneca Company Details
  10.7.2 AstraZeneca Business Overview and Its Total Revenue
  10.7.3 AstraZeneca Respiratory Disorders Drugs Introduction
  10.7.4 AstraZeneca Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.7.5 AstraZeneca Recent Development
10.8 Boehringer Ingelheim International
  10.8.1 Boehringer Ingelheim International Company Details
  10.8.2 Boehringer Ingelheim International Business Overview and Its Total Revenue
  10.8.3 Boehringer Ingelheim International Respiratory Disorders Drugs Introduction
  10.8.4 Boehringer Ingelheim International Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.8.5 Boehringer Ingelheim International Recent Development
10.9 Vertex Pharmaceuticals Incorporated
  10.9.1 Vertex Pharmaceuticals Incorporated Company Details
  10.9.2 Vertex Pharmaceuticals Incorporated Business Overview and Its Total Revenue
  10.9.3 Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Introduction
  10.9.4 Vertex Pharmaceuticals Incorporated Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.9.5 Vertex Pharmaceuticals Incorporated Recent Development
10.10 Roche
  10.10.1 Roche Company Details
  10.10.2 Roche Business Overview and Its Total Revenue
  10.10.3 Roche Respiratory Disorders Drugs Introduction
  10.10.4 Roche Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.10.5 Roche Recent Development
10.11 GlaxoSmithKline
  10.11.1 GlaxoSmithKline Company Details
  10.11.2 GlaxoSmithKline Business Overview and Its Total Revenue
  10.11.3 GlaxoSmithKline Respiratory Disorders Drugs Introduction
  10.11.4 GlaxoSmithKline Revenue in Respiratory Disorders Drugs Business (2015-2020)
  10.11.5 GlaxoSmithKline Recent Development

11ANALYST'S VIEWPOINTS/CONCLUSIONS

12APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Respiratory Disorders Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Respiratory Disorders Drugs Revenue
Table 3. Ranking of Global Top Respiratory Disorders Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Respiratory Disorders Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Nasal
Table 7. Key Players of Injectable
Table 8. COVID-19 Impact Global Market: (Four Respiratory Disorders Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Respiratory Disorders Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Respiratory Disorders Drugs Players to Combat Covid-19 Impact
Table 13. Global Respiratory Disorders Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Respiratory Disorders Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Respiratory Disorders Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Respiratory Disorders Drugs Market Share by Regions (2015-2020)
Table 17. Global Respiratory Disorders Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Respiratory Disorders Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Respiratory Disorders Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Respiratory Disorders Drugs Players
Table 24. Global Respiratory Disorders Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Respiratory Disorders Drugs Market Share by Players (2015-2020)
Table 26. Global Top Respiratory Disorders Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disorders Drugs as of 2019)
Table 27. Global Respiratory Disorders Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Respiratory Disorders Drugs Product Solution and Service
Table 30. Date of Enter into Respiratory Disorders Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Respiratory Disorders Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Respiratory Disorders Drugs Market Size Share by Type (2015-2020)
Table 34. Global Respiratory Disorders Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Respiratory Disorders Drugs Market Size Share by Application (2015-2020)
Table 36. Global Respiratory Disorders Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Respiratory Disorders Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Respiratory Disorders Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Respiratory Disorders Drugs Market Share (2019-2020)
Table 40. North America Respiratory Disorders Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Respiratory Disorders Drugs Market Share by Type (2015-2020)
Table 42. North America Respiratory Disorders Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Respiratory Disorders Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Respiratory Disorders Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Respiratory Disorders Drugs Market Share (2019-2020)
Table 46. Europe Respiratory Disorders Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Respiratory Disorders Drugs Market Share by Type (2015-2020)
Table 48. Europe Respiratory Disorders Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Respiratory Disorders Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Respiratory Disorders Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Respiratory Disorders Drugs Market Share (2019-2020)
Table 52. China Respiratory Disorders Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Respiratory Disorders Drugs Market Share by Type (2015-2020)
Table 54. China Respiratory Disorders Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Respiratory Disorders Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Respiratory Disorders Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Respiratory Disorders Drugs Market Share (2019-2020)
Table 58. Japan Respiratory Disorders Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Respiratory Disorders Drugs Market Share by Type (2015-2020)
Table 60. Japan Respiratory Disorders Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Respiratory Disorders Drugs Market Share by Application (2015-2020)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Product
Table 65. Novartis Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 66. Novartis Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Product
Table 70. Sanofi Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 71. Sanofi Recent Development
Table 72. Teva Pharmaceutical Company Details
Table 73. Teva Pharmaceutical Business Overview
Table 74. Teva Pharmaceutical Product
Table 75. Teva Pharmaceutical Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 76. Teva Pharmaceutical Recent Development
Table 77. Merck & Co. Company Details
Table 78. Merck & Co. Business Overview
Table 79. Merck & Co. Product
Table 80. Merck & Co. Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 81. Merck & Co. Recent Development
Table 82. Sumitomo Dainippon Pharma Company Details
Table 83. Sumitomo Dainippon Pharma Business Overview
Table 84. Sumitomo Dainippon Pharma Product
Table 85. Sumitomo Dainippon Pharma Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 86. Sumitomo Dainippon Pharma Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Product
Table 90. Mylan Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 91. Mylan Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Product
Table 95. AstraZeneca Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 96. AstraZeneca Recent Development
Table 97. Boehringer Ingelheim International Business Overview
Table 98. Boehringer Ingelheim International Product
Table 99. Boehringer Ingelheim International Company Details
Table 100. Boehringer Ingelheim International Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 101. Boehringer Ingelheim International Recent Development
Table 102. Vertex Pharmaceuticals Incorporated Company Details
Table 103. Vertex Pharmaceuticals Incorporated Business Overview
Table 104. Vertex Pharmaceuticals Incorporated Product
Table 105. Vertex Pharmaceuticals Incorporated Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 106. Vertex Pharmaceuticals Incorporated Recent Development
Table 107. Roche Company Details
Table 108. Roche Business Overview
Table 109. Roche Product
Table 110. Roche Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 111. Roche Recent Development
Table 112. GlaxoSmithKline Company Details
Table 113. GlaxoSmithKline Business Overview
Table 114. GlaxoSmithKline Product
Table 115. GlaxoSmithKline Revenue in Respiratory Disorders Drugs Business (2015-2020) (Million US$)
Table 116. GlaxoSmithKline Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Respiratory Disorders Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Nasal Features
Figure 4. Injectable Features
Figure 5. Global Respiratory Disorders Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Respiratory Disorders Drugs Report Years Considered
Figure 9. Global Respiratory Disorders Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Respiratory Disorders Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Respiratory Disorders Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Respiratory Disorders Drugs Market Share by Players in 2019
Figure 14. Global Top Respiratory Disorders Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disorders Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Respiratory Disorders Drugs Revenue in 2019
Figure 16. North America Respiratory Disorders Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Respiratory Disorders Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Respiratory Disorders Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Respiratory Disorders Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Novartis Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 22. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Sanofi Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 24. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Teva Pharmaceutical Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 26. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Merck & Co. Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 28. Sumitomo Dainippon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sumitomo Dainippon Pharma Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 30. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Mylan Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 32. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AstraZeneca Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 34. Boehringer Ingelheim International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Boehringer Ingelheim International Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 36. Vertex Pharmaceuticals Incorporated Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 38. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Roche Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 40. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. GlaxoSmithKline Revenue Growth Rate in Respiratory Disorders Drugs Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed